JD Health International, Inc. (HK:6618) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
JD Health International, Inc. reported a significant rise in revenue and profits for the third quarter of 2024, with revenue increasing by 14.8% and profit surging by 212.2% compared to the same period in 2023. The company expanded its pharmaceutical offerings and online medical services, enhancing its service model by integrating online consultations and at-home testing services in major cities like Beijing and Shanghai. JD Health also introduced online payment services through medical insurance accounts, further solidifying its position in the healthcare market.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue